The New York Stem Cell Foundation Opens New Research Institute and Headquarters in Manhattan

NEW YORK–(BUSINESS WIRE)– The New York Stem Cell Foundation (NYSCF) today officially opened its
new 40,000 square foot Research Institute in Manhattan, one of the
largest laboratories in the world devoted exclusively to stem cell
research. The new facility, which also contains the headquarters of
NYSCF, an independent, non-profit organization founded in 2005 to
support cutting-edge stem cell research, will allow scientists to
conduct the most advanced research to develop new and better treatments
and cures. This new facility will expand NYSCF’s capabilities and
capacity to build novel technological resources for the stem cell field.

This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20170419006643/en/

The New York Stem Cell Foundation (NYSCF) holds official ribbon cutting ceremony to open new NYSCF Research Institute & Headquarters.
Pictured: Howard Zemsky (President, CEO & Commissioner, Empire State Development); Roy Geronemus MD,(Founding Chairman of the Board for NYSCF); Michael R. Bloomberg, Founder, Bloomberg LP & Bloomberg Philanthropies and three term New York City Mayor; Susan L. Solomon (CEO & Co-Founder of NYSCF); Stephen M. Ross (Chairman & Founder of Related Companies, NYSCF Board Member); Tony Coles MD (Chairman & Founder, Yumanity Therapeutics); James Patchett (President & CEO, New York City Economic Development Corporation)
(Photo credit: Bloomberg Philanthropies)

The new NYSCF complex includes a glass-enclosed laboratory housing the
NYSCF Global Stem Cell Array, a unique, NYSCF-developed automated
robotic technology for manufacturing stem cell lines with unmatched
quality in large scale, among other cell culture facilities. NYSCF will
also have a highly specialized GMP laboratory facility for manufacturing
cells for therapies. Additional laboratories include molecular biology,
imaging, cell sorting, and electrophysiology suites, and extensive bench
space.

“Opening this new world class research laboratory is the culmination of
our vision to build the infrastructure for stem cell research and
therapeutics,” said Susan L. Solomon, NYSCF CEO and Co-founder. “As
NYSCF is increasingly becoming a global hub of stem cell research and
regenerative medicine, our new home will enable new partnerships with
global bioscience and research institutions, accelerate the development
of new treatments and cures, and further strengthen New York City as a
center for biomedical research.”

Key NYSCF collaborators, supporters, and friends speaking at the opening
ceremony and ribbon cutting, include:

• Michael R. Bloomberg, Founder, Bloomberg LP & Bloomberg Philanthropies
  and three term New York City Mayor
• Stephen M. Ross, Chairman and Founder, Related Companies and NYSCF
  Board Member
• Tony Coles, MD, Chairman and Chief Executive Officer, Yumanity
  Therapeutics
• Howard Zemsky, President and Chief Executive Officer, Empire State
  Development
• James Patchett, President & CEO, New York City Economic Development
  Corporation

The new NYSCF facility, which was designed by Ennead Architects, also
contains numerous conference and meeting suites, in addition to an
expansive common area for collaborative and interactive work. A large
lecture hall equipped with the latest multimedia technologies solidifies
and expands NYSCF’s role and capabilities as a key convening resource
and host for scientists in the greater New York metropolitan region.

Since 2005, NYSCF has supported and pioneered innovation in science,
producing some of the most significant discoveries in human stem cell
research to advance the entire field. All the while, patients have
remained the sole focus of NYSCF’s mission to find cures.

NYSCF’s unique model of research – an independent, largely privately
funded foundation and safe haven laboratories – continues to push the
boundaries of medical research and redefine what the field believes to
be possible. By pursuing high-risk, high reward research that
traditional funding models do not support, and developing innovative
solutions to overcome rate-limiting challenges to the entire field,
NYSCF is accelerating new and better treatments and cures for patients
around the world.

“The New York Stem Cell Foundation is a critical partner to New York’s
research institutions and is doing great things in terms of finding
treatments and cures for the most vexing diseases,” said U.S. Senator
Charles Schumer. “We in New York are at the center of biomedical
research and the new NYSCF facility will enhance that centrality.”

“This facility is home to some of the most brilliant scientists and
researchers in the field of stem cell research, and we are so fortunate
to have it right here in New York,” said U.S. Senator Kirsten
Gillibrand. “The men and women who work here are bringing us closer
every day to finding new cures and treatments that would help millions
of families around the world.”

Michael R. Bloomberg stated, “It’s great to be celebrating such a
wonderful milestone for the New York Stem Cell Foundation. In just 12
years, this organization has grown from one office with a handful of
employees to an enormous group of researchers around the world. The New
York Stem Cell Foundation strengthens New York City as a global center
of research and innovation, and it goes without saying that the next
twelve years will be as even more exciting to watch as this institute
grow and matures.”

Stephen Ross, Chairman and Founder of Related Companies and NYSCF Board
member said, “We can all take great pride that the New York Stem Cell
Foundation, led by Susan Solomon, are doing the most advanced stem cell
research in the world, right here in New York City, and now in a
state-of-the-art facility. NYSCF is without a doubt, one of New York’s
great entrepreneurial successes of the last decade and as the nation’s
leader in the production of stem cells, they are now poised for dramatic
growth. I am pleased to have played a role in the creation of a
world-class home for NYSCF and encourage everyone to support their
important work as stem cell research is key to improving and saving
people’s lives.”

“The NYSCF is a jewel in the New York City life sciences ecosystem,”
said Dr. Tony Coles, Chairman and CEO of Yumanity Therapeutics. “The
biotechnology community looks forward to pushing back the frontiers of
science in collaboration with this dynamic organization.”

Empire State Development President, CEO & Commissioner Howard Zemsky
stated, “The State’s investment in the New York Stem Center Foundation’s
state-of-the-art laboratory is a smart investment in innovation, in
progress, and in our future. We are proud to support this groundbreaking
work which is spurring the creation of more than 30 new jobs over the
next five years. With this project, New York State further establishes
itself as the premier hub for advancements and breakthroughs in the
burgeoning life sciences industry.”

“The growth of New York City’s life sciences sector is critical in our
efforts to create 100,000 high-quality jobs over the next decade,” said
NYCEDC President and CEO James Patchett. “Since its inception, the New
York Stem Cell Foundation’s innovative research and tireless advocacy
has helped build a foundation for this important industry. We are
thrilled to welcome their new, state-of-the-art headquarters, which will
create more good jobs and further solidify New York City as a premier
destination for the life sciences.”

About The New York Stem Cell Foundation Research Institute

The New York Stem Cell Foundation (NYSCF) Research Institute is an
independent organization accelerating cures and better treatments for
patients through stem cell research. The NYSCF global community includes
over 140 researchers at leading institutions worldwide, including the
NYSCF – Druckenmiller Fellows, the NYSCF – Robertson Investigators, the
NYSCF – Robertson Stem Cell Prize Recipients, and NYSCF Research
Institute scientists and engineers. The NYSCF Research Institute is an
acknowledged world leader in stem cell research and in developing
pioneering stem cell technologies, including the NYSCF Global Stem Cell
ArrayTM and in manufacturing stem cells for scientists around the globe.
NYSCF focuses on translational research in a model designed to overcome
the barriers that slow discovery and replace silos with collaboration.
For more information, visit www.nyscf.org.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170419006643/en/